Cargando…

Mitochondria: a new therapeutic target in chronic kidney disease

Cellular metabolic changes during chronic kidney disease (CKD) may induce higher production of oxygen radicals that play a significant role in the progression of renal damage and in the onset of important comorbidities. This condition seems to be in part related to dysfunctional mitochondria that ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granata, Simona, Dalla Gassa, Alessandra, Tomei, Paola, Lupo, Antonio, Zaza, Gianluigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660721/ https://www.ncbi.nlm.nih.gov/pubmed/26612997 http://dx.doi.org/10.1186/s12986-015-0044-z

Ejemplares similares

Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease
por: Granata, Simona, et al.
Publicado: (2016)

Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in “Omics” Medicine
por: Zaza, Gianluigi, et al.
Publicado: (2015)

Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen
por: Zaza, Gianluigi, et al.
Publicado: (2017)

Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease
por: Signorini, Lorenzo, et al.
Publicado: (2017)

Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects
por: Granata, Simona, et al.
Publicado: (2016)

Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects
por: Zaza, Gianluigi, et al.
Publicado: (2014)

In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets
por: Granata, Simona, et al.
Publicado: (2018)

Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
por: Zaza, Gianluigi, et al.
Publicado: (2013)

Downregulation of Nuclear-Encoded Genes of Oxidative Metabolism in Dialyzed Chronic Kidney Disease Patients
por: Zaza, Gianluigi, et al.
Publicado: (2013)

A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients
por: Zaza, Gianluigi, et al.
Publicado: (2013)

NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients
por: Granata, Simona, et al.
Publicado: (2015)

Hairy cell leukemia in kidney transplantation: lesson from a rare disorder
por: Vinante, Fabrizio, et al.
Publicado: (2013)

Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury
por: Masola, Valentina, et al.
Publicado: (2018)

How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center
por: Zaza, Gianluigi, et al.
Publicado: (2015)

Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease
por: Granata, Simona, et al.
Publicado: (2009)

Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase
por: Masola, Valentina, et al.
Publicado: (2013)

mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
por: Granata, Simona, et al.
Publicado: (2021)

Inflammasome pathway in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023)

Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients
por: Zaza, Gianluigi, et al.
Publicado: (2014)

Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants
por: Granata, Simona, et al.
Publicado: (2022)

Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury
por: Cantoni, Claudia, et al.
Publicado: (2020)

mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023)

mRNA as a medicine in nephrology: the future is now
por: Granata, Simona, et al.
Publicado: (2023)

In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells
por: Masola, Valentina, et al.
Publicado: (2019)

Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease
por: Bruschi, Maurizio, et al.
Publicado: (2019)

Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease
por: La Russa, Antonella, et al.
Publicado: (2023)

The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential
por: Zhang, Xiaoqin, et al.
Publicado: (2021)

Editorial of Special Issue “Rare Kidney Diseases: New Translational Research Approach to Improve Diagnosis and Therapy”
por: Zaza, Gianluigi, et al.
Publicado: (2020)

Skin cancer in solid organ transplant recipients: still an open problem
por: Granata, Simona, et al.
Publicado: (2023)

A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease
por: Bruschi, Maurizio, et al.
Publicado: (2022)

A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
por: Masola, Valentina, et al.
Publicado: (2012)

Sphingomyelin and Medullary Sponge Kidney Disease: A Biological Link Identified by Omics Approach
por: Granata, Simona, et al.
Publicado: (2021)

Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study
por: Bruschi, Maurizio, et al.
Publicado: (2022)

Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide
por: Tan, Sih Min, et al.
Publicado: (2021)

Autophagy Activation in Peripheral Blood Mononuclear Cells of Peritoneal Dialysis Patients
por: Granata, Simona, et al.
Publicado: (2023)

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Mitochondria-targeted drugs for diabetic kidney disease
por: Mima, Akira
Publicado: (2022)

The Effect of Polyphenols on Kidney Disease: Targeting Mitochondria
por: Ashkar, Fatemeh, et al.
Publicado: (2022)

Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease
por: Fairley, Lauren H., et al.
Publicado: (2023)

Is VEGF a new therapeutic target for hypertension in chronic kidney disease?
por: Kim, Yon Su
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iedjd1hse5rbcqq9atfq9dn3mt